Patents by Inventor Ilaria Zambaldi

Ilaria Zambaldi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for loading at least two powder substances into recesses provided at a stent surface
    Patent number: 11141509
    Abstract: In an embodiment, a method for loading a powder substance (10) into recesses (200) provided at a stent (S) surface, the method comprises: applying compression (100) to the powder substance (10) to thereby form tablets insertable into said recesses (200), inserting the tablets into the recesses (200) of the stent (S).
    Type: Grant
    Filed: March 28, 2017
    Date of Patent: October 12, 2021
    Assignee: CID S.P.A.
    Inventors: Ilaria Zambaldi, Franco Vallana, Matteo Antoniotti, Andrea Grignani
  • STENTS FOR THE RELEASE OF ACTIVE PRINCIPLES
    Publication number: 20190125940
    Abstract: In an embodiment, a stent (S) implantable in a vessel of a patient, comprises recesses (200) loaded with an active principle with anti-inflammatory activity (10) and an active principle with anti-proliferative activity (20). The active principle with anti-inflammatory activity (10) and the active principle with anti-proliferative activity (20) have respective formulations, whereby the active principle with anti-inflammatory activity (10)and the active principle with anti-proliferative activity (20) have respective release kinetics as a function of said formulations, with the release of the active principle with anti-inflammatory activity (10) being faster than the release of the active principle with anti-proliferative activity (20).
    Type: Application
    Filed: March 28, 2017
    Publication date: May 2, 2019
    Inventors: Ilaria Zambaldi, Franco Vallana, Matteo Antoniotti, Andrea Grignani
  • IMPROVEMENTS IN STENTS FOR THE RELEASE OF ACTIVE PRINCIPLES
    Publication number: 20190117852
    Abstract: A stent for the controlled release of at least two active principles having anti-proliferative activity and anti-inflammatory activity, respectively, with different release kinetic profiles from each other.
    Type: Application
    Filed: March 28, 2017
    Publication date: April 25, 2019
    Inventors: Ilaria Zambaldi, Franco Vallana, Matteo Antoniotti, Andrea Grignani
  • IMPROVEMENTS IN STENTS FOR THE RELEASE OF ACTIVE PRINCIPLES
    Publication number: 20190091378
    Abstract: In an embodiment, a method for loading a powder substance (10) into recesses (200) provided at a stent (S) surface, the method comprises: applying compression (100) to the powder substance (10) to thereby form tablets insertable into said recesses (200), inserting the tablets into the recesses (200) of the stent (S).
    Type: Application
    Filed: March 28, 2017
    Publication date: March 28, 2019
    Inventors: Ilaria Zambaldi, Franco Vallana, Matteo Antoniotti, Andrea Grignani
  • Composition for active principles delivery containing a fatty acid excipient
    Patent number: 9011898
    Abstract: Composition for delivery of at least one active principle at the implantation site of an implant device, including: at least one active principle, and at least a first excipient combined with the at least one active principle, wherein the at least a first excipient is selected among fatty acids with a linear or branched, saturated chain, including a number of carbon atoms between 14 and 36.
    Type: Grant
    Filed: September 19, 2011
    Date of Patent: April 21, 2015
    Assignee: CID S.p.A.
    Inventors: Maria Curcio, Ilaria Zambaldi, Daniela Gramaglia, Andrea Grignani
  • COMPOSITION FOR ACTIVE PRINCIPLES DELIVERY BY IMPLANT DEVICES
    Publication number: 20130280315
    Abstract: Composition for delivery of at least one active principle at the implantation site of an implant device, including: at least one active principle, and at least a first excipient combined with the at least one active principle, wherein the at least a first excipient is selected among fatty acids with a linear or branched, saturated chain, including a number of carbon atoms between 14 and 36.
    Type: Application
    Filed: September 19, 2011
    Publication date: October 24, 2013
    Inventors: Maria Curcio, Ilaria Zambaldi, Daniela Gramaglia, Andrea Grignani
  • Hydrogel interferon formulations
    Patent number: 7879320
    Abstract: The present invention is related to pharmaceutical Poloxamer hydrogel formulations containing an interferon. In particular, the invention relates to sustained release hydrogel formulations of interferon-beta, method of preparation and use thereof.
    Type: Grant
    Filed: May 13, 2005
    Date of Patent: February 1, 2011
    Assignee: Ares Trading S.A.
    Inventors: Maria Dorly Del Curto, Ilaria Zambaldi, Silvia Pompili, Pierandrea Esposito
  • Hydrogel Interferon Formulations
    Publication number: 20070248674
    Abstract: The present invention is related to pharmaceutical Poloxamer hydrogel formulations containing an interferon. In particular, the invention relates to sustained release hydrogel formulations of interferon-beta, method of preparation and use thereof.
    Type: Application
    Filed: May 13, 2005
    Publication date: October 25, 2007
    Applicant: Ares Trading S.A.
    Inventors: Maria Del Curto, Ilaria Zambaldi, Silvia Pompili, Pierandrea Esposito